Literature DB >> 21537562

Implications of HAM/TSP functional incapacity in the quality of life.

Marcia Shublaq1, Marco Orsini, Marzia Puccioni-Sohler.   

Abstract

OBJECTIVE: To identify the functional status and quality of life of HAM/TSP patients.
METHOD: We evaluated prospectively 30 HAM/TSP patients (20 females) seen in the Neuroinfection Clinic of the HUGG. The functional capacity was analyzed by the functional independence measure (FIM), the expanded disability status (EDSS) scale and the Osame's motor disability score (OMDS). The quality of life was assessed by the Short-Form Health Survey 36 (SF-36)TM.
RESULTS: All patients need assistance device. The FIM, OMDS and EDSS scores classified 70%, 67% and 67% of the patients as dependent, respectively. The lowest scores of the SF-36 survey were found in the domains related to the physical health (D1, D2), role-emotional functioning (D7) and social functioning (D6).
CONCLUSION: Our data suggest that the HAM/TSP physical impairment has an impact in the emotional and social issues, considering the limitation in the daily activities.

Entities:  

Mesh:

Year:  2011        PMID: 21537562     DOI: 10.1590/s0004-282x2011000200013

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  8 in total

1.  Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Authors:  Ana Verena Galvão-Castro; Ney Boa-Sorte; Ramon Almeida Kruschewsky; Maria Fernanda Rios Grassi; Bernardo Galvão-Castro
Journal:  Qual Life Res       Date:  2011-11-23       Impact factor: 4.147

2.  Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

Authors:  G A S Dias; G T Yoshikawa; R V L Koyama; S Fujihara; L C S Martins; R Medeiros; J A S Quaresma; H T Fuzii
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

3.  A plasma diagnostic model of human T-cell leukemia virus-1 associated myelopathy.

Authors:  Makoto Ishihara; Natsumi Araya; Tomoo Sato; Naomi Saichi; Risa Fujii; Yoshihisa Yamano; Koji Ueda
Journal:  Ann Clin Transl Neurol       Date:  2015-01-16       Impact factor: 4.511

4.  Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: The impact of a neglected disease on the quality of life.

Authors:  Carolina Rosadas; Tatiane Assone; Marina Yamashita; Adine Adonis; Marzia Puccioni-Sohler; Marisa Santos; Arthur Paiva; Jorge Casseb; Augusto C P Oliveira; Graham P Taylor
Journal:  PLoS Negl Trop Dis       Date:  2020-10-16

5.  Health-Related Quality of Life Evaluation Using the Short Form-36 in Patients With Human T-Lymphotropic Virus Type 1-Associated Myelopathy.

Authors:  Miyuna Kimura; Junji Yamauchi; Tomoo Sato; Naoko Yagishita; Natsumi Araya; Satoko Aratani; Kenichiro Tanabe; Erika Horibe; Toshiki Watanabe; Ariella Coler-Reilly; Misako Nagasaka; Yukari Akasu; Kei Kaburagi; Takayuki Kikuchi; Soichiro Shibata; Hirofumi Matsumoto; Akihito Koseki; Soichiro Inoue; Ayako Takata; Yoshihisa Yamano
Journal:  Front Med (Lausanne)       Date:  2022-04-11

6.  Work ability and associated factors in people living with human T-cell leukemia virus type 1.

Authors:  Dayana Alves Costa; Fernando Martins Carvalho; Nicolle Melo Vieira; Gleicy Gabriela Spínola Carneiro Falcão; Viviane Almeida Sarmento; Carlos Brites; Liliane Lins-Kusterer
Journal:  Rev Soc Bras Med Trop       Date:  2022-08-05       Impact factor: 2.141

7.  Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test.

Authors:  Adine Adonis; Graham P Taylor
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

8.  Quality of life, risk behaviors and depression among carriers of hepatitis C virus and human T-cell lymphotropic virus type 1: a comparative study.

Authors:  Ricardo Henrique-Araújo; Lucas C Quarantini; André C Caribé; Felipe C Argolo; Ana Paula Jesus-Nunes; Mychelle Morais-de-Jesus; Adriana Dantas-Duarte; Tayne Miranda Moreira; Irismar Reis de Oliveira
Journal:  Braz J Infect Dis       Date:  2019-07-22       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.